Kalbito

FDA OKs CSL’s new HAE drug, already embroiled in a blockbuster fight with Shire
Endpoints
Fri, 06/23/17 - 09:48 am
FDA
CSL
HAE
hereditary angiodema
Shire
Haegarda
Firazyr
Kalbito